The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids

Imagem de Miniatura
Arquivos
art_FELIZARDO_The_interplay_among_gut_microbiota_hypertension_and_kidney_2019.PDF (1.11 MB)
Citações na Scopus
100
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Autores
FELIZARDO, R. J. F.
WATANABE, I. K. M.
DARDI, Patrizia
ROSSONI, L. V.
Citação
PHARMACOLOGICAL RESEARCH, v.141, p.366-377, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The bacteria community living in the gut maintains a symbiotic relationship with the host and its unbalance has been associated with progression of a wide range of intestinal and extra intestinal conditions. Hypertension and chronic kidney disease (CKD) are closely associated diseases with high incidence rates all over the world. Increasing data have supported the involvement of gut microbiome in the blood pressure regulation and the impairment of CKD prognosis. In hypertension, the reduced number of short-chain fatty acids (SCFAs) producing bacteria is associated with modifications in gut environment, involving reduction of the hypoxic gut profile and worsening of the microbial balance, leading to a loss of epithelial barrier integrity, development of gut inflammation and the reduction of SCFAs plasma levels. These modifications compromise the blood pressure regulation and, as a consequence, favor the end organ damage, also affecting the kidneys. In CKD, impaired renal function leads to accumulation of high levels of uremic toxins that reach the intestine and cause alterations in bacteria composition and fecal metabolite profile, inducing a positive feedback that allows translocation of endotoxins into the bloodstream, which enhances local kidney inflammation and exacerbate kidney injury, compromising even more CKD prognosis. In line with these data, the use of prebiotics, probiotics and fecal microbiota transplantation are becoming efficient therapies to improve the gut dysbiosis aiming hypertension and CKD treatment. This review describes how changes in gut microbiota composition can affect the development of hypertension and the progression of kidney diseases, highlighting the importance of the gut microbial composition uncovering to improve human health maintenance and, especially, for the development of new alternative therapies.
Palavras-chave
Hypertension, Chronic kidney disease, Inflammation, Gut microbiota, Short chain fatty acids
URI
https://observatorio.fm.usp.br/handle/OPI/32002
Referências
  1. Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
  2. Adam A, 2001, J NUTR, V131, P1770
  3. Ahren IL, 2015, CLIN NUTR, V34, P719, DOI 10.1016/j.clnu.2014.08.009
  4. Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105
  5. Andersen K, 2017, J AM SOC NEPHROL, V28, P76, DOI 10.1681/ASN.2015111285
  6. Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288
  7. Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012
  8. BAEZ S, 1971, J EXP MED, V134, P846, DOI 10.1084/jem.134.4.846
  9. Barton W, 2018, GUT, V67, P625, DOI 10.1136/gutjnl-2016-313627
  10. Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013
  11. Bier A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091154
  12. Bloemen JG, 2009, CLIN NUTR, V28, P657, DOI 10.1016/j.clnu.2009.05.011
  13. Bolognini D, 2016, MOL PHARMACOL, V89, P388, DOI 10.1124/mol.115.102301
  14. Bossola M, 2009, CLIN J AM SOC NEPHRO, V4, P379, DOI 10.2215/CJN.03490708
  15. Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200
  16. Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149
  17. Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191
  18. Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329
  19. Carvalho-Ramos II, 2018, J PEDIAT-BRAZIL, V94, P258, DOI 10.1016/j.jped.2017.05.013
  20. Chakraborty S, 2018, CELL REP, V25, P677, DOI 10.1016/j.celrep.2018.09.058
  21. Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001
  22. Comte J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00112
  23. Coppa GV, 2004, J CLIN GASTROENTEROL, V38, pS80, DOI 10.1097/01.mcg.0000128926.14285.25
  24. Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17
  25. David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
  26. Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S
  27. De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
  28. den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
  29. Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043
  30. Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245
  31. Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280
  32. Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
  33. Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150
  34. Perez-Cobas AE, 2013, GUT, V62, P1591, DOI [10.4161/gmic.27128, 10.1136/gutjnl-2012-303184]
  35. Evans P.D., 2011, MEDICINE, V39, P402
  36. Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439
  37. Felizardo RJF, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.36
  38. Flint Harry J, 2012, Gut Microbes, V3, P289, DOI 10.4161/gmic.19897
  39. Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611
  40. Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176
  41. Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111
  42. Galla S, 2018, PHYSIOL GENOMICS, V50, P837, DOI 10.1152/physiolgenomics.00073.2018
  43. Gao B, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0150-9
  44. Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059
  45. Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7
  46. Gomez-Guzman M, 2015, MOL NUTR FOOD RES, V59, P2326, DOI 10.1002/mnfr.201500290
  47. Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
  48. Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164
  49. Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
  50. Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13
  51. Harrison DG, 2013, J AM SOC HYPERTENS, V7, P68, DOI 10.1016/j.jash.2012.11.007
  52. HATCH M, 1994, J AM SOC NEPHROL, V5, P1339
  53. HATCH M, 1994, CLIN SCI, V86, P511, DOI 10.1042/cs0860511
  54. Hatch M, 2013, UROLITHIASIS, V41, P379, DOI 10.1007/s00240-013-0601-8
  55. Hocher B, 2017, NAT REV NEPHROL, V13, P269, DOI 10.1038/nrneph.2017.30
  56. Holmes AJ, 2017, CELL METAB, V25, P140, DOI 10.1016/j.cmet.2016.10.021
  57. Holzapfel WH, 1998, INT J FOOD MICROBIOL, V41, P85, DOI 10.1016/S0168-1605(98)00044-0
  58. Hughes-Large JM, 2014, ATHEROSCLEROSIS, V237, P696, DOI 10.1016/j.atherosclerosis.2014.10.090
  59. Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
  60. Ichii O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108448
  61. Jang HR, 2009, AM J PHYSIOL-RENAL, V297, pF1457, DOI 10.1152/ajprenal.90769.2008
  62. Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3
  63. Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007
  64. Johnson RJ, 2005, J AM SOC NEPHROL, V16, P1909, DOI 10.1681/ASN.2005010063
  65. Karbach SH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003698
  66. Keddis MT, 2012, MAYO CLIN PROC, V87, P1046, DOI 10.1016/j.mayocp.2012.05.025
  67. Khalesi S, 2014, HYPERTENSION, V64, P897, DOI 10.1161/HYPERTENSIONAHA.114.03469
  68. Kim A, 2015, J CLIN GASTROENTEROL, V49, pS20, DOI 10.1097/MCG.0000000000000356
  69. Kim S, 2018, CLIN SCI, V132, P701, DOI [10.1042/cs20180087, 10.1042/CS20180087]
  70. Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108
  71. Kobayashi N, 2002, NEPHRON, V91, P480, DOI 10.1159/000064291
  72. Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
  73. Koppe L, 2015, KIDNEY INT, V88, P958, DOI 10.1038/ki.2015.255
  74. Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238
  75. Krishnamurthy VMR, 2012, KIDNEY INT, V81, P300, DOI 10.1038/ki.2011.355
  76. Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200
  77. Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568
  78. Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x
  79. Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
  80. Li QR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00120
  81. Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
  82. Lyte M, 2014, ADV EXP MED BIOL, V817, P3, DOI 10.1007/978-1-4939-0897-4_1
  83. MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x
  84. Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833
  85. Macpherson AJ, 2001, MICROBES INFECT, V3, P1021, DOI 10.1016/S1286-4579(01)01460-5
  86. Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713
  87. Marques FZ, 2017, CIRCULATION, V135, P964, DOI 10.1161/CIRCULATIONAHA.116.024545
  88. Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729
  89. Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704
  90. Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052
  91. Meijers BKI, 2010, NEPHROL DIAL TRANSPL, V25, P219, DOI 10.1093/ndt/gfp414
  92. Mell B, 2015, PHYSIOL GENOMICS, V47, P187, DOI 10.1152/physiolgenomics.00136.2014
  93. Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589
  94. Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085
  95. Monhart V, 2013, COR VASA, V55, pE397, DOI 10.1016/j.crvasa.2013.07.006
  96. Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082
  97. MORTENSEN FV, 1994, PHARMACOL TOXICOL, V75, P181, DOI 10.1111/j.1600-0773.1994.tb00344.x
  98. Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x
  99. Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585
  100. Mullane KM, 2013, AM J NEPHROL, V38, P1, DOI 10.1159/000351757
  101. Muntner P, 2010, AM J KIDNEY DIS, V55, P441, DOI 10.1053/j.ajkd.2009.09.014
  102. Natarajan N, 2016, PHYSIOL GENOMICS, V48, P826, DOI 10.1152/physiolgenomics.00089.2016
  103. NIWA T, 1994, AM J NEPHROL, V14, P207, DOI 10.1159/000168716
  104. Omenetti S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00639
  105. Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309
  106. Pirkle JL, 2013, MINERVA UROL NEFROL, V65, P37
  107. Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110
  108. Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106
  109. Poesen R, 2016, J AM SOC NEPHROL, V27, P1389, DOI 10.1681/ASN.2015030279
  110. Ravera M, 2006, J AM SOC NEPHROL, V17, pS98, DOI 10.1681/ASN.2005121319
  111. Reese AT, 2018, NAT MICROBIOL, V3, P1441, DOI 10.1038/s41564-018-0267-7
  112. Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42
  113. Rossi M, 2016, CLIN J AM SOC NEPHRO, V11, P223, DOI 10.2215/CJN.05240515
  114. Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8
  115. Santisteban MM, 2017, CIRC RES, V120, P312, DOI 10.1161/CIRCRESAHA.116.309006
  116. Saran R., 2018, USRDS ANN DATA REPOR
  117. Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
  118. Sharaf El Din Usama Abdel Azim, 2016, World J Nephrol, V5, P258, DOI 10.5527/wjn.v5.i3.258
  119. Shi KH, 2014, DIGEST DIS SCI, V59, P2109, DOI 10.1007/s10620-014-3202-7
  120. Siener R, 2013, KIDNEY INT, V83, P1144, DOI 10.1038/ki.2013.104
  121. Sirich TL, 2014, CLIN J AM SOC NEPHRO, V9, P1603, DOI 10.2215/CJN.00490114
  122. Sleator RD, 2010, MED HYPOTHESES, V74, P214, DOI 10.1016/j.mehy.2009.08.047
  123. Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974
  124. Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007
  125. Stripling J, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv078
  126. Suez J., 2018, CELL, V174, DOI [10.1016/j.cell.2018.08.047 e16, DOI 10.1016/J.CELL.2018.08.047E16]
  127. Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047
  128. Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445
  129. Suryavanshi MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34712
  130. Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733
  131. Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149
  132. Tedla FM, 2011, INT J HYPERTENS, DOI 10.4061/2011/132405
  133. Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466
  134. Tuomilehto J, 2004, J HUM HYPERTENS, V18, P795, DOI 10.1038/sj.jhh.1001745
  135. Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
  136. Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881
  137. Vaziri ND, 2013, AM J NEPHROL, V37, P1, DOI 10.1159/000345969
  138. Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345
  139. Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858
  140. Waghulde H, 2018, HYPERTENSION, V72, P1125, DOI 10.1161/HYPERTENSIONAHA.118.11175
  141. Wanders D, 2012, BIOCHEM BIOPH RES CO, V425, P278, DOI 10.1016/j.bbrc.2012.07.082
  142. Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x
  143. Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490
  144. Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336
  145. Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628
  146. Wilson M., 2005, ROLE INDIGENOUS MICR, P375
  147. Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010
  148. Wu B, 2017, NEPHRON, V135, P156, DOI 10.1159/000452453
  149. Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100
  150. Xu H, 2017, CLIN J AM SOC NEPHRO, V12, P1399, DOI 10.2215/CJN.00250117
  151. Yang GL, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0394-2
  152. Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315
  153. Yang X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006074
  154. Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5
  155. Zhou T, 2016, J PHYSIOL-LONDON, V594, P4225, DOI 10.1113/JP271936
  156. ZWEIFACH BW, 1958, J EXP MED, V107, P437, DOI 10.1084/jem.107.3.437

Coleções
Artigos e Materiais de Revistas Científicas - LIM/05
Artigos e Materiais de Revistas Científicas - ODS/03